Spiriva FDA Approval History
FDA Approved: Yes (First approved January 30, 2004)
Brand name: Spiriva
Generic name: tiotropium bromide
Dosage form: Inhalation Powder
Company: Boehringer Ingelheim
Treatment for: COPD, Maintenance
Spiriva HandiHaler (tiotropium bromide) is an anticholinergic indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations.
Development Timeline for Spiriva
|Dec 18, 2009||ApprovalFDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations|
|Jan 30, 2004||ApprovalSpiriva HandiHaler Boehringer Ingelheim - Treatment for Chronic Obstructive Pulmonary Disease (COPD)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.